This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Kaneka Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Katsuo Noguchi: Innovator in Lymphocyte Proliferation Technology
Introduction
Katsuo Noguchi is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of medical technology, particularly in the area of lymphocyte proliferation. His innovative work has led to the development of a unique patent that addresses critical needs in body fluid treatment.
Latest Patents
Katsuo Noguchi holds a patent for an "Adsorbent for lymphocyte proliferation inhibitor and treating method." This invention relates to a porous material designed for body fluid treatment, which promotes lymphocyte proliferation in lymphocyte culture. The material contains a high-molecular compound with a contact angle with water ranging from 40 to 98 degrees. Additionally, it includes activated carbon and is associated with various methods for proliferating lymphocytes, producing mammalian lymphocytes, and creating pharmaceutical compositions. The patent also outlines a treatment device that utilizes this porous material.
Career Highlights
Throughout his career, Katsuo Noguchi has worked with notable companies such as Kaneka Corporation and Riken Immune Regenerative Medicine Inc. His experience in these organizations has allowed him to refine his expertise in medical technology and innovation.
Collaborations
Katsuo has collaborated with esteemed colleagues, including Akira Kobayashi and Shinya Yoshida. These partnerships have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Katsuo Noguchi's work in lymphocyte proliferation technology exemplifies the impact of innovative thinking in the medical field. His patent and collaborations highlight his commitment to advancing healthcare solutions. His contributions continue to influence the landscape of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
